Allspring Global Investments Holdings, LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,379
-62.2%
482
-65.1%
0.00%
Q2 2023$64,525
+25.2%
1,382
+2.6%
0.00%
Q1 2023$51,536
-38.6%
1,347
-12.1%
0.00%
Q4 2022$83,953
+58.4%
1,532
-2.2%
0.00%
Q3 2022$53,0001,5660.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
University of Wisconsin Foundation 103,816$5,251,0136.02%
Boxer Capital, LLC 1,676,733$84,809,1554.52%
Redmile Group, LLC 1,769,684$89,510,6174.26%
Ghost Tree Capital, LLC 250,000$12,645,0004.16%
Logos Global Management LP 600,000$30,348,0004.05%
COMMODORE CAPITAL LP 565,000$28,577,7003.34%
Yiheng Capital Management, L.P. 1,221,674$61,792,2713.15%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$10,116,0003.07%
Atlas Venture Life Science Advisors, LLC 359,251$18,170,9152.81%
Perceptive Advisors 1,619,425$81,910,5172.73%
View complete list of AKERO THERAPEUTICS INC shareholders